Ultragenyx Pharmaceutical (RARE) Statistics

Ultragenyx Pharmaceutical Inc (RARE) is a biopharmaceutical company focused on the development and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases. The company's stock statistics provide valuable insights into its performance in the market. These statistics include metrics such as the stock's valuation, fundamentals, and revenue per share. Understanding these metrics can help investors assess the potential value of investing in Ultragenyx Pharmaceutical Inc.

One important valuation metric for Ultragenyx Pharmaceutical Inc is the Enterprise to EBITDA ratio, which measures the company's ability to generate earnings relative to its enterprise value. A lower ratio suggests that the stock may be undervalued, while a higher ratio may indicate overvaluation. Another key metric is the Profit Margin, which measures the company's profitability by calculating the percentage of revenue that remains as profit after all expenses are deducted. A higher profit margin suggests higher profitability.